Literature DB >> 2306833

Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity.

K A Ellenbogen1, M D Thames, J P DiMarco, H Sheehan, B B Lerman.   

Abstract

After cardiac transplantation, the denervated donor atria and ventricles demonstrate increased sensitivity to infusions of sympathomimetic amines. Recently, supersensitivity of the canine sinus and atrioventricular (AV) nodes to acetylcholine has also been demonstrated after parasympathetic denervation. Acetylcholine and the endogenous nucleoside adenosine exert similar electrophysiological effects in both the sinus and AV nodes, and share a common transduction process. We, therefore, hypothesized that after orthotopic cardiac transplantation, the donor (denervated) sinus node would demonstrate greater sensitivity to exogenous adenosine than the recipient (innervated) sinus node. The effects of incremental doses of intravenous adenosine (37-112 micrograms/kg) on changes in sinus cycle length (SCL) (delta SCLmax%), changes in PR interval (delta PRmax%), time to peak effect (sec), and duration of electrophysiological effects (sec) were prospectively measured in 28 orthotopic cardiac transplant patients and nine control subjects. The baseline SCL was 795 +/- 71 msec for the control subjects, 891 +/- 43 msec for the recipient atria, and 700 +/- 18 msec for the donor atria (p less than 0.05, donor vs. recipient). The delta SCLmax% for each dose of adenosine was similar in the innervated control and recipient atria. In contrast, the donor sinus node demonstrated a threefold to fourfold increased response to adenosine as compared with the recipient sinus node and a threefold to sixfold increased response as compared with control subjects. Similarly, the donor AV node demonstrated a threefold to fivefold increase in PR interval as compared with control subjects. The duration of sinus node slowing in the denervated atria was threefold to fivefold longer than in the recipient and control atria (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306833     DOI: 10.1161/01.cir.81.3.821

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Sinus arrest during adenosine stress testing in liver transplant recipients with graft failure: three case reports and a review of the literature.

Authors:  Kenneth N Giedd; Sabahat Bokhari; Teresa P Daniele; Lynne L Johnson
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

Review 2.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

3.  Regadenoson-induced hyperemia for absolute myocardial blood flow quantitation by 13N-ammonia PET and detection of cardiac allograft vasculopathy.

Authors:  René R Sevag Packard; Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2017-01-30       Impact factor: 5.952

Review 4.  Device Management in Heart Failure.

Authors:  Brett G Angel; Heath Saltzman; Luke S Kusmirek
Journal:  Curr Cardiol Rep       Date:  2017-09-25       Impact factor: 2.931

5.  Posttransplant pacemaker placement: case series and review.

Authors:  Mark A Thompson; Hamang Patel
Journal:  Ochsner J       Date:  2010

6.  Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients.

Authors:  João L Cavalcante; Joaquim Barboza; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2011-05-28       Impact factor: 5.952

Review 7.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

8.  Safety of adenosine pharmacologic stress myocardial perfusion imaging in orthotopic cardiac transplant recipients: a single center experience of 102 transplant patients.

Authors:  Mouaz H Al-Mallah; Muhammad Arida; Enrique Garcia-Sayan; Chafik Assal; Gino Tapia Zegarra; Barbara Czerska; Karthik Ananthasubramaniam
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-19       Impact factor: 2.357

9.  Safety of regadenoson positron emission tomography stress testing in orthotopic heart transplant patients.

Authors:  John J Lazarus; Ashraf Saleh; Michael Ghannam; Keith Aaronson; Monica Colvin; Frank Pagani; Todd Koelling; James R Corbett; Richard L Weinberg; Venkatesh L Murthy; Matthew C Konerman
Journal:  J Nucl Cardiol       Date:  2018-11-27       Impact factor: 5.952

10.  Arrhythmias in the Heart Transplant Patient.

Authors:  David Hamon; Jane Taleski; Marmar Vaseghi; Kalyanam Shivkumar; Noel G Boyle
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.